Avoid Valeant (VRX) Stock?

Valeant Pharmaceuticals International (VRX 37.00) has garnered a lot of news lately. Valeant's stock continues to rise after the company won approval from loan holders to amend terms of the company’s debt, granting the pharmaceutical company an additional month to file its annual report.
Read More

Revolutionary Stocks Survey Results Well Known vs. Unknown Stocks A Network Security Provider --- Last week, reviewing the 10 Revolutionary Stocks I'd presented over the previous 10 weeks, I asked you which ones you owned. You answered (at least enough of you did), and today I present results,...
Read More